Letter to the editor: HBeAg expression suppressing/abolishing mutation elevated HBV DNA level in HBeAg‐negative patients with chronic HBV infection
Danli Yang, Jun Zou, Leijie Wang, Xiangmei Chen, Fengmin Lu – 4 April 2022
Monitoring cardiovascular risk factors after liver transplantation may improve outcomes
Sarah R. Lieber, Lisa B. VanWagner – 4 April 2022
Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient
Patricia P. Bloom, John Donlan, Mariam Torres Soto, Michael Daidone, Elizabeth Hohmann, Raymond T. Chung – 4 April 2022 – Early data suggest fecal microbiota transplant (FMT) may treat hepatic encephalopathy (HE). Optimal FMT donor and recipient characteristics are unknown. We assessed the safety and efficacy of FMT in patients with prior overt HE, comparing five FMT donors. We performed an open‐label study of FMT capsules, administered 5 times over 3 weeks. Primary outcomes were change in psychometric HE score (PHES) and serious adverse events (SAEs).
Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD
Ziming An, Qiaohong Liu, Wenli Zeng, Yan Wang, Qian Zhang, Huafu Pei, Xin Xin, Shuohui Yang, Fang Lu, Yu Zhao, Yiyang Hu, Qin Feng – 4 April 2022 – We used cross‐sectional and longitudinal studies to comprehensively compare hepatic steatosis measurements obtained with magnetic resonance imaging–proton density fat fraction (MRI‐PDFF) and controlled attenuated parameter (CAP) in hepatic steatosis in adults with nonalcoholic fatty liver disease (NAFLD). A total of 185 participants with NAFLD and 12 non‐NAFLD controls were recruited.
Letter to the editor: The burgeoning field of progressive familial intrahepatic cholestasis
Claudia Mandato, Pietro Vajro – 4 April 2022
CAQ Corner: Pediatric indications for liver transplantation
Jennifer Vittorio – 3 April 2022
CAQ Corner: Pediatric indications for liver transplantation
Jennifer Vittorio – 3 April 2022
Identification of hepatic steatosis in living liver donors by machine learning models
Jihye Lim, Seungbong Han, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Dong Hwan Jung, Sung‐Gyu Lee, Ki‐Hun Kim, Jonggi Choi – 3 April 2022 – Selecting an optimal donor for living donor liver transplantation is crucial for the safety of both the donor and recipient, and hepatic steatosis is an important consideration. We aimed to build a prediction model with noninvasive variables to evaluate macrovesicular steatosis in potential donors by using various prediction models.